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Introduction
Arterial or venous thrombosis rarely occurs in children,
in almost 70% of these patients an acquired or congeni-
tal cause can be identified. Hereditary thrombophilia
can be identified in 10-30% of children with other evi-
dent causes of thrombosis, and in 60% of children with
apparent idiopathic thrombosis. Therefore it is sug-
gested that thrombophilia screening should be done in
both cases.
Objectives
Aim of this study was to look for thrombophilia in a
cohort of children with thrombotic events.
Methods
The clinical records of all patients admitted to the
Pediatric Clinic, the Pediatric Intensive Care Unit and
Neuropsychiatry of the Children Hospital of Brescia
between January 2006 and January 2012 were analyzed
to select those with either clinical history or discharge
diagnosis of an acute thrombotic event. Patients with
malignancy were excluded. The selected patients were
analyzed for clinical history, characteristics of the
thrombotic event and possible predisposing causes and
underwent a complete screening for thrombophilia.
Results
30 out of the 6379 children whose charts had been eval-
uated met the inclusion criteria; in none of them throm-
bophilia was previously diagnosed. Mean age was 5.0 ±
3.7 years, 17/30 were males, 19 had arterial and 11
venous thrombosis. Central nervous system was involved
in 28 patients, veins of legs in 2. 4 children died during
the hospitalization; the other 26 were contacted: 21
agreed to undergo a clinical evaluation and complete
screening for thrombophilia.
Family history was significant in 9 patients (4 cerebral
ischemia, 1 acute myocardial infarction, 1 cerebral ische-
mia and myocardial infarction, 1 deep vein thrombosis, 1
LAC positivity and 1 recurrent abortion). Possible predis-
posing causes were found in 6 children: cardiopathy (2),
otomastoiditis (1), trauma (1) venous cannulation (2).
Protein C was low (54% and 61%) in 2 children and
Protein S in other 2 (63% and 31%). A child had an het-
erozygous mutation for Factor II, two (9,5%) hyperomo-
cysteinemia associated with homozygosity for variant
C677T of MTHFR. Significant positivity for Antipho-
spholipid Antibodies was found in 2 children: one for
anti-B2GPI IgM (0.504 UO) and one double positivity
for anticardiolipin IgG (25.4 GPL) and anti-B2GPI IgG
(0.199 UO), allowing the diagnosis of Antiphospholipid
Antibody Syndrome (APS).
Conclusion
Thrombophilia was found in 9 out of the 21 children
studied. In 3 children there were both a thrombophilic
and acquired predisposing condition: one Protein C def-
icit and otomastoiditis, one Protein S deficit and cardio-
pathy and one Antiphospholipid Antibodies Syndrome
and cardiopathy. The other 6 children had been found
to have hereditary thrombophilia or Antiphospholipid
Antibody Syndrome, without any extrinsic predisposing
factor and all of them had been previously diagnosed as
idiopathic thrombosis. Our study underlines the impor-
tance to do a complete screening for thrombophilia in
all children with thrombosis. Moreover, even though
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underlines that some patients may be misdiagnosed
without appropriate screening in case of a child present-
ing with a thrombotic event.
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